| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma Protein | 80 | 2023 | 671 | 11.440 |
Why?
|
| E2F Transcription Factors | 49 | 2023 | 270 | 4.980 |
Why?
|
| Drosophila Proteins | 38 | 2021 | 1712 | 4.760 |
Why?
|
| Drosophila melanogaster | 20 | 2014 | 1726 | 2.540 |
Why?
|
| E2F1 Transcription Factor | 20 | 2022 | 182 | 2.380 |
Why?
|
| Transcription Factors | 57 | 2023 | 12168 | 2.370 |
Why?
|
| Cell Cycle Proteins | 46 | 2023 | 3445 | 2.320 |
Why?
|
| Cell Cycle | 37 | 2023 | 2932 | 1.730 |
Why?
|
| Drosophila | 20 | 2021 | 1513 | 1.570 |
Why?
|
| DNA-Binding Proteins | 49 | 2017 | 9615 | 1.530 |
Why?
|
| Chromatin | 17 | 2023 | 2981 | 1.250 |
Why?
|
| Trans-Activators | 13 | 2017 | 2857 | 1.250 |
Why?
|
| Chromosomal Instability | 4 | 2014 | 176 | 1.170 |
Why?
|
| E2F2 Transcription Factor | 10 | 2014 | 35 | 1.090 |
Why?
|
| Carrier Proteins | 29 | 2004 | 4937 | 1.070 |
Why?
|
| Oncogene Proteins, Viral | 15 | 2006 | 342 | 1.010 |
Why?
|
| Histone Demethylases | 4 | 2015 | 328 | 0.960 |
Why?
|
| Fat Body | 3 | 2021 | 32 | 0.880 |
Why?
|
| Oxidoreductases, N-Demethylating | 4 | 2015 | 109 | 0.830 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1890 | 0.820 |
Why?
|
| Retinoblastoma | 8 | 2021 | 321 | 0.790 |
Why?
|
| Gene Expression Regulation | 20 | 2015 | 11928 | 0.770 |
Why?
|
| S Phase | 16 | 2014 | 424 | 0.760 |
Why?
|
| Nuclear Proteins | 25 | 2014 | 5804 | 0.740 |
Why?
|
| Histones | 10 | 2014 | 2601 | 0.740 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2021 | 8647 | 0.710 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2021 | 101 | 0.690 |
Why?
|
| Repressor Proteins | 14 | 2011 | 2982 | 0.650 |
Why?
|
| Small Cell Lung Carcinoma | 5 | 2024 | 454 | 0.630 |
Why?
|
| Cyclin-Dependent Kinase 4 | 7 | 2019 | 565 | 0.630 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2014 | 724 | 0.630 |
Why?
|
| Chromosome Structures | 1 | 2018 | 11 | 0.620 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2019 | 354 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2021 | 3610 | 0.600 |
Why?
|
| Transcription, Genetic | 18 | 2021 | 7608 | 0.600 |
Why?
|
| Adenosine Triphosphatases | 4 | 2012 | 842 | 0.590 |
Why?
|
| Apoptosis | 19 | 2019 | 9523 | 0.580 |
Why?
|
| Cyclin-Dependent Kinases | 8 | 2008 | 663 | 0.580 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 25 | 2000 | 138 | 0.580 |
Why?
|
| Animals | 104 | 2024 | 169246 | 0.570 |
Why?
|
| Histone Code | 1 | 2018 | 160 | 0.570 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 501 | 0.560 |
Why?
|
| Cell Proliferation | 12 | 2019 | 10474 | 0.550 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2014 | 384 | 0.550 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2014 | 2810 | 0.530 |
Why?
|
| Mitosis | 8 | 2013 | 1178 | 0.520 |
Why?
|
| Cell Division | 15 | 2023 | 4473 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 287 | 0.510 |
Why?
|
| DNA Replication | 13 | 2022 | 1427 | 0.490 |
Why?
|
| Centromere | 3 | 2014 | 214 | 0.490 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2015 | 393 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2014 | 710 | 0.490 |
Why?
|
| Methylation | 9 | 2014 | 1078 | 0.490 |
Why?
|
| Cell Nucleus | 4 | 2022 | 2885 | 0.480 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 781 | 0.470 |
Why?
|
| DNA Damage | 11 | 2022 | 2469 | 0.460 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2013 | 2954 | 0.440 |
Why?
|
| Genes, Retinoblastoma | 9 | 2012 | 125 | 0.430 |
Why?
|
| Transcription Factor DP1 | 20 | 2003 | 136 | 0.430 |
Why?
|
| G1 Phase | 11 | 2009 | 403 | 0.420 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 525 | 0.420 |
Why?
|
| Protein Binding | 21 | 2024 | 9343 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2024 | 5341 | 0.420 |
Why?
|
| Signal Transduction | 13 | 2019 | 23645 | 0.420 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2013 | 701 | 0.410 |
Why?
|
| Cell Line, Tumor | 18 | 2022 | 17140 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2024 | 998 | 0.410 |
Why?
|
| Eye | 9 | 2011 | 712 | 0.390 |
Why?
|
| Metabolism | 1 | 2013 | 193 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2016 | 2846 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1901 | 0.380 |
Why?
|
| Suppression, Genetic | 5 | 2006 | 190 | 0.380 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3428 | 0.380 |
Why?
|
| Proteins | 10 | 2001 | 6009 | 0.370 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2023 | 858 | 0.370 |
Why?
|
| Phosphoproteins | 10 | 2001 | 2451 | 0.360 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1074 | 0.350 |
Why?
|
| RNA Interference | 9 | 2015 | 2832 | 0.350 |
Why?
|
| Neoplasms | 11 | 2018 | 22371 | 0.340 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 352 | 0.340 |
Why?
|
| Phenotype | 16 | 2022 | 16726 | 0.340 |
Why?
|
| Glutamine | 1 | 2013 | 577 | 0.340 |
Why?
|
| Mutation | 25 | 2023 | 30238 | 0.330 |
Why?
|
| Genomic Instability | 6 | 2023 | 716 | 0.330 |
Why?
|
| Intestine, Small | 1 | 2015 | 1217 | 0.320 |
Why?
|
| Animals, Genetically Modified | 8 | 2014 | 1563 | 0.310 |
Why?
|
| Papillomaviridae | 6 | 2005 | 1140 | 0.310 |
Why?
|
| E2F7 Transcription Factor | 1 | 2008 | 2 | 0.300 |
Why?
|
| Phosphorylation | 10 | 2019 | 8317 | 0.300 |
Why?
|
| Blotting, Western | 8 | 2016 | 5027 | 0.280 |
Why?
|
| Retinoblastoma-Like Protein p107 | 11 | 2001 | 70 | 0.280 |
Why?
|
| Larva | 4 | 2013 | 515 | 0.270 |
Why?
|
| Anaphase | 1 | 2006 | 112 | 0.270 |
Why?
|
| Chromosome Segregation | 3 | 2014 | 230 | 0.270 |
Why?
|
| Histone Deacetylases | 5 | 2022 | 717 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2001 | 4528 | 0.260 |
Why?
|
| Cell Survival | 7 | 2017 | 5777 | 0.260 |
Why?
|
| Embryonic Structures | 1 | 2005 | 10 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 170 | 0.260 |
Why?
|
| Gene Silencing | 3 | 2016 | 1505 | 0.250 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 1110 | 0.250 |
Why?
|
| Molecular Sequence Data | 27 | 2006 | 17622 | 0.240 |
Why?
|
| Mitochondria | 3 | 2015 | 3681 | 0.230 |
Why?
|
| Embryonic Development | 2 | 2008 | 724 | 0.230 |
Why?
|
| Binding Sites | 12 | 2014 | 6020 | 0.230 |
Why?
|
| Epithelial Cells | 2 | 2016 | 3703 | 0.230 |
Why?
|
| Cyclins | 5 | 2000 | 606 | 0.220 |
Why?
|
| Amino Acid Sequence | 22 | 2006 | 13421 | 0.220 |
Why?
|
| Antigens, Polyomavirus Transforming | 5 | 2009 | 256 | 0.220 |
Why?
|
| Cells, Cultured | 16 | 2015 | 19015 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2024 | 3611 | 0.220 |
Why?
|
| Adenovirus E1A Proteins | 4 | 2005 | 81 | 0.220 |
Why?
|
| Cell Line | 12 | 2022 | 15597 | 0.220 |
Why?
|
| DNA | 10 | 2022 | 7214 | 0.220 |
Why?
|
| beta Catenin | 1 | 2008 | 1047 | 0.210 |
Why?
|
| Gene Deletion | 5 | 2014 | 2675 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 4 | 2023 | 2830 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 111 | 0.210 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 13586 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 8 | 2022 | 5797 | 0.200 |
Why?
|
| Humans | 86 | 2024 | 768166 | 0.200 |
Why?
|
| Insect Proteins | 2 | 2000 | 253 | 0.200 |
Why?
|
| Mice | 39 | 2024 | 82029 | 0.200 |
Why?
|
| Cell Transformation, Viral | 5 | 2006 | 530 | 0.200 |
Why?
|
| Cyclin E | 5 | 2006 | 155 | 0.200 |
Why?
|
| Receptors, Notch | 3 | 2011 | 751 | 0.200 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 242 | 0.200 |
Why?
|
| Alleles | 7 | 2012 | 6894 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 301 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3800 | 0.190 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2022 | 108 | 0.190 |
Why?
|
| Cytidine Deaminase | 1 | 2023 | 249 | 0.190 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1151 | 0.190 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2013 | 168 | 0.180 |
Why?
|
| Genes, Insect | 2 | 1999 | 265 | 0.180 |
Why?
|
| Transfection | 8 | 2016 | 5755 | 0.180 |
Why?
|
| Autophagy | 2 | 2022 | 1349 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 3 | 2019 | 5446 | 0.180 |
Why?
|
| Models, Biological | 7 | 2013 | 9495 | 0.180 |
Why?
|
| In Situ Hybridization | 4 | 2012 | 1903 | 0.180 |
Why?
|
| Nucleotides | 2 | 2013 | 455 | 0.180 |
Why?
|
| HeLa Cells | 7 | 2015 | 3074 | 0.180 |
Why?
|
| Retinoblastoma-Like Protein p130 | 5 | 2001 | 72 | 0.180 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 261 | 0.170 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 762 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6124 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3080 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7876 | 0.170 |
Why?
|
| Gene Amplification | 1 | 2024 | 1095 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2005 | 944 | 0.160 |
Why?
|
| Aspergillus nidulans | 2 | 1989 | 8 | 0.160 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 151 | 0.160 |
Why?
|
| Sirtuin 1 | 2 | 2011 | 247 | 0.160 |
Why?
|
| DNA Repair | 4 | 2018 | 2050 | 0.160 |
Why?
|
| Polyomavirus | 2 | 1990 | 235 | 0.160 |
Why?
|
| Cullin Proteins | 2 | 2010 | 180 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2016 | 1062 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 742 | 0.150 |
Why?
|
| DNA Methylation | 2 | 2016 | 4428 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 173 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4580 | 0.150 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.150 |
Why?
|
| Cyclin D3 | 1 | 2017 | 54 | 0.140 |
Why?
|
| Multigene Family | 2 | 2012 | 1081 | 0.140 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.140 |
Why?
|
| Genome | 3 | 2023 | 1754 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1120 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2010 | 284 | 0.140 |
Why?
|
| Oncogenes | 3 | 1999 | 1234 | 0.140 |
Why?
|
| Stress, Physiological | 2 | 2015 | 1408 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 948 | 0.130 |
Why?
|
| Blotting, Northern | 4 | 2005 | 1550 | 0.130 |
Why?
|
| Heterochromatin | 2 | 2011 | 294 | 0.130 |
Why?
|
| Serine | 2 | 2017 | 831 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2012 | 3803 | 0.130 |
Why?
|
| Proteomics | 3 | 2021 | 3912 | 0.130 |
Why?
|
| Polyadenylation | 1 | 2016 | 114 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 21206 | 0.120 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 183 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 633 | 0.120 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3833 | 0.120 |
Why?
|
| Fasting | 2 | 2013 | 1610 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 905 | 0.120 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 20 | 0.120 |
Why?
|
| Transcriptional Activation | 9 | 2002 | 1750 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2014 | 56 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2015 | 135 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 103 | 0.110 |
Why?
|
| MyoD Protein | 1 | 2014 | 143 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2015 | 217 | 0.110 |
Why?
|
| Papillomavirus E7 Proteins | 5 | 2006 | 110 | 0.110 |
Why?
|
| Neuropeptides | 2 | 2012 | 951 | 0.110 |
Why?
|
| Adenovirus Early Proteins | 7 | 1992 | 58 | 0.110 |
Why?
|
| Cadherins | 2 | 2009 | 905 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 482 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 1999 | 2748 | 0.100 |
Why?
|
| Origin Recognition Complex | 1 | 2012 | 20 | 0.100 |
Why?
|
| Testis | 1 | 1996 | 783 | 0.100 |
Why?
|
| Ubiquitin | 2 | 2008 | 843 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 806 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2013 | 404 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2885 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 234 | 0.100 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2011 | 39 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1606 | 0.100 |
Why?
|
| RNA, Fungal | 2 | 1989 | 156 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1143 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2010 | 1966 | 0.090 |
Why?
|
| Eye Neoplasms | 3 | 1990 | 306 | 0.090 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 257 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 628 | 0.090 |
Why?
|
| Lysine | 2 | 2013 | 1000 | 0.090 |
Why?
|
| Mice, Knockout | 10 | 2008 | 14488 | 0.090 |
Why?
|
| Cell Differentiation | 7 | 2006 | 11669 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3671 | 0.090 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2011 | 183 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 589 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Base Sequence | 13 | 1996 | 12421 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2014 | 1760 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1406 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 515 | 0.080 |
Why?
|
| Lysosomes | 1 | 2015 | 938 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 3772 | 0.080 |
Why?
|
| Glioma | 2 | 2002 | 3503 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 979 | 0.080 |
Why?
|
| DNA Tumor Viruses | 1 | 1989 | 4 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3620 | 0.080 |
Why?
|
| Genomics | 2 | 2018 | 5926 | 0.080 |
Why?
|
| JC Virus | 1 | 1989 | 87 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1989 | 153 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 3 | 2005 | 910 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 1989 | 292 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2062 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2013 | 1219 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2474 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 663 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2002 | 1683 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2008 | 49 | 0.080 |
Why?
|
| Neurons | 4 | 2001 | 9514 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11878 | 0.080 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 194 | 0.080 |
Why?
|
| Glycolysis | 3 | 2017 | 837 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 138 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 1757 | 0.080 |
Why?
|
| Phthalazines | 2 | 2022 | 397 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1524 | 0.070 |
Why?
|
| Mice, Mutant Strains | 6 | 2006 | 1754 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2011 | 1647 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 182 | 0.070 |
Why?
|
| Research | 1 | 2016 | 1979 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 1996 | 1989 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1367 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2012 | 2433 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1801 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2000 | 855 | 0.070 |
Why?
|
| Genes, myc | 1 | 2008 | 391 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2002 | 2179 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2227 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2012 | 1968 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2521 | 0.070 |
Why?
|
| Aneuploidy | 2 | 2012 | 573 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2005 | 3447 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 1999 | 557 | 0.070 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2006 | 89 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2002 | 3464 | 0.070 |
Why?
|
| Cell Death | 3 | 2012 | 1679 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 414 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 2892 | 0.070 |
Why?
|
| Female | 20 | 2019 | 397192 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2012 | 1530 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2010 | 2937 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2005 | 752 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 3728 | 0.060 |
Why?
|
| Fibroblasts | 5 | 2013 | 4176 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 317 | 0.060 |
Why?
|
| RNA, Messenger | 6 | 2015 | 12800 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18349 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2002 | 3603 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3139 | 0.060 |
Why?
|
| Precipitin Tests | 3 | 2003 | 816 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2004 | 3 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Purines | 2 | 2019 | 615 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1990 | 1057 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 268 | 0.060 |
Why?
|
| Aminopyridines | 2 | 2019 | 580 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5902 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 725 | 0.060 |
Why?
|
| Homozygote | 3 | 2005 | 1779 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1162 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2012 | 1276 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 1992 | 1142 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 1430 | 0.060 |
Why?
|
| Transgenes | 2 | 2005 | 1016 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1988 | 905 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2009 | 3590 | 0.050 |
Why?
|
| Organisms, Genetically Modified | 1 | 2002 | 63 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2002 | 930 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 185 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6082 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1656 | 0.050 |
Why?
|
| Growth Inhibitors | 2 | 1994 | 375 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2002 | 63 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2009 | 1611 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 335 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2202 | 0.050 |
Why?
|
| Chromosomes | 1 | 2005 | 578 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2001 | 453 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 1839 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 185 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 203 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4352 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2003 | 223 | 0.050 |
Why?
|
| Gene Expression | 4 | 1998 | 7598 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 713 | 0.050 |
Why?
|
| Fetal Death | 1 | 2003 | 434 | 0.050 |
Why?
|
| Trehalose | 1 | 2021 | 88 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2024 | 481 | 0.050 |
Why?
|
| Ovary | 1 | 2005 | 965 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 321 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4446 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2633 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4912 | 0.040 |
Why?
|
| Caspases | 2 | 2001 | 882 | 0.040 |
Why?
|
| Cyclin D | 1 | 2000 | 71 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 262 | 0.040 |
Why?
|
| DCMP Deaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Piperazines | 2 | 2022 | 2554 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2002 | 200 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13676 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2024 | 1883 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2004 | 778 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2002 | 376 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 414 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2008 | 2575 | 0.040 |
Why?
|
| Genes, cdc | 1 | 1999 | 113 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 366 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2002 | 538 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11101 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11095 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 3055 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2909 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 606 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 432 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 189 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2006 | 2043 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 2 | 1994 | 36 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 279 | 0.040 |
Why?
|
| Gene Targeting | 4 | 2006 | 841 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 887 | 0.040 |
Why?
|
| Protein Stability | 2 | 2010 | 580 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 1999 | 214 | 0.040 |
Why?
|
| Phosphofructokinase-1 | 1 | 2017 | 50 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1997 | 148 | 0.040 |
Why?
|
| Nervous System | 1 | 2000 | 544 | 0.040 |
Why?
|
| Gamma Rays | 1 | 1998 | 319 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 387 | 0.040 |
Why?
|
| Vinblastine | 1 | 1998 | 487 | 0.030 |
Why?
|
| Male | 10 | 2021 | 364719 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2017 | 126 | 0.030 |
Why?
|
| Retinal Dysplasia | 1 | 1996 | 12 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 10099 | 0.030 |
Why?
|
| Exocrine Glands | 1 | 1996 | 46 | 0.030 |
Why?
|
| Muscles | 1 | 2021 | 1582 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1994 | 4168 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1996 | 117 | 0.030 |
Why?
|
| Telomerase | 1 | 2001 | 751 | 0.030 |
Why?
|
| Vincristine | 1 | 1998 | 1040 | 0.030 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2001 | 1676 | 0.030 |
Why?
|
| Retroelements | 1 | 2016 | 162 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 191 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5703 | 0.030 |
Why?
|
| Quinazolines | 1 | 2002 | 1373 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2016 | 219 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 22379 | 0.030 |
Why?
|
| Chimera | 1 | 1996 | 454 | 0.030 |
Why?
|
| Phylogeny | 1 | 2002 | 2843 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 330 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1998 | 622 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2006 | 1640 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 417 | 0.030 |
Why?
|
| Response Elements | 1 | 2015 | 307 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 40218 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 257 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 596 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 672 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3623 | 0.030 |
Why?
|
| Fetus | 1 | 2000 | 1883 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2627 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 325 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1992 | 260 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1996 | 528 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1996 | 717 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1992 | 174 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 10760 | 0.020 |
Why?
|
| Cell Nucleolus | 2 | 2004 | 156 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1674 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1497 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1993 | 828 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2429 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1996 | 1802 | 0.020 |
Why?
|
| Plasmids | 2 | 1994 | 2269 | 0.020 |
Why?
|
| Prognosis | 3 | 2019 | 30010 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1525 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2253 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2010 | 1470 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14729 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
| Atrophy | 1 | 1996 | 1646 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 4058 | 0.020 |
Why?
|
| Extremities | 1 | 1996 | 870 | 0.020 |
Why?
|
| Naphthols | 1 | 2010 | 46 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2019 | 10101 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 2 | 2001 | 133 | 0.020 |
Why?
|
| Mice, Transgenic | 4 | 2006 | 9561 | 0.020 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2009 | 13 | 0.020 |
Why?
|
| Longevity | 1 | 1998 | 1077 | 0.020 |
Why?
|
| DNA Viruses | 1 | 1990 | 33 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2001 | 281 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1996 | 945 | 0.020 |
Why?
|
| Haplorhini | 1 | 1990 | 523 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2149 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1716 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1667 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2002 | 9118 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1996 | 1375 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1767 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 711 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2001 | 730 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1989 | 275 | 0.020 |
Why?
|
| Papio | 1 | 1990 | 671 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 418 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1989 | 440 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 866 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 322 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 3048 | 0.020 |
Why?
|
| Retroviridae | 1 | 1990 | 846 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3568 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 1988 | 227 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1898 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1607 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4120 | 0.020 |
Why?
|
| Homeostasis | 2 | 2015 | 3348 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3914 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6793 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1009 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 4772 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1990 | 2094 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 2204 | 0.010 |
Why?
|
| Benzamides | 1 | 2010 | 1379 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 379 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 4786 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2907 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4283 | 0.010 |
Why?
|
| Virus Replication | 1 | 1992 | 2458 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 5812 | 0.010 |
Why?
|
| DNA Polymerase III | 1 | 2004 | 52 | 0.010 |
Why?
|
| Peptides | 2 | 1992 | 4354 | 0.010 |
Why?
|
| Liver | 2 | 2015 | 7577 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2195 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 392 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 224 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13671 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 1151 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6395 | 0.010 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2001 | 21 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 123 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 26 | 0.010 |
Why?
|
| Hydro-Lyases | 1 | 2001 | 93 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2005 | 489 | 0.010 |
Why?
|
| Lamins | 1 | 2000 | 37 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2914 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9419 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 223492 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 530 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 1999 | 33 | 0.010 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2001 | 303 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 1832 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 1536 | 0.010 |
Why?
|
| Lamin Type A | 1 | 2000 | 190 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3343 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1135 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1999 | 133 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1084 | 0.010 |
Why?
|
| Glutathione Transferase | 2 | 1991 | 564 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 4035 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 1999 | 212 | 0.010 |
Why?
|
| Brain | 2 | 2011 | 27360 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26379 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Camptothecin | 1 | 2001 | 600 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 906 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1228 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 9263 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 171504 | 0.010 |
Why?
|
| Rats | 2 | 1991 | 23760 | 0.010 |
Why?
|
| Stem Cells | 2 | 2001 | 3537 | 0.010 |
Why?
|
| Kinetics | 2 | 1996 | 6329 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1998 | 714 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1103 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1999 | 588 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2001 | 854 | 0.010 |
Why?
|
| Body Weight | 2 | 1996 | 4627 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1765 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 6514 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1194 | 0.010 |
Why?
|
| Growth Plate | 1 | 1996 | 276 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20760 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 394 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59629 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 1993 | 35 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 1993 | 8 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2678 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1435 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1994 | 111 | 0.010 |
Why?
|
| Species Specificity | 1 | 1998 | 2415 | 0.010 |
Why?
|
| Germinal Center | 1 | 1996 | 380 | 0.010 |
Why?
|
| Bone Development | 1 | 1996 | 473 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65371 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1991 | 3740 | 0.010 |
Why?
|
| Cartilage | 1 | 1996 | 811 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2798 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1996 | 965 | 0.010 |
Why?
|
| Mammals | 1 | 1996 | 1135 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2682 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1996 | 911 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 455 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1998 | 1322 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2828 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1996 | 1346 | 0.000 |
Why?
|
| Actins | 1 | 1996 | 2064 | 0.000 |
Why?
|
| Adult | 2 | 2019 | 223646 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2725 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4427 | 0.000 |
Why?
|
| Adenoviridae | 1 | 1990 | 1092 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 4620 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2662 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 1385 | 0.000 |
Why?
|
| Keratinocytes | 1 | 1989 | 876 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1998 | 2360 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2565 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4978 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 30256 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 54926 | 0.000 |
Why?
|